Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Jubilant Biosys Adds Agilent's RapidFire/MS Screening Platform | Contract Pharma

What are you searching for?

Sign in
Breaking News

Jubilant Biosys Adds Agilent’s RapidFire/MS Screening Platform

Becomes first facility in India to be equipped with the RapidFire Mass Spec technology

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Jubilant Biosys has added Agilent Technologies’ RapidFire/MS screening technology to its drug discovery platform.
 
RapidFire is a solid phase extraction technology that enables label-free detection of native compounds by mass spectrometry in a wide range of in vitro assays, DMPK/ADME studies, hit/lead applications for drug discovery, as well as screening difficult targets that are not amenable to labeled assays. Jubilant’s Bengaluru facility will be the first in India to be equipped with the RapidFire High-Throughput Mass Spectrometry system technology.
 
“The installation of the Agilent RapidFire platform shows Jubilant’s continued commitment to make the necessary investments with an objective to remain on the cutting edge of drug discovery. This platform will enable us to increase our productivity and to enhance our capabilities to successfully meet the needs of our clients,” said Steven Hutchins, president, Jubilant Biosys.
 
“Agilent RapidFire solution enables our clients with increased accuracy, provides faster results, better economic value, enhanced analysis capabilities, improved efficiency while maintaining robustness and we are pleased to see Jubilant Biosys being the first organization in India to take advantage of this cutting-edge technology,” said Bharat Bhardwaj, country manager, Agilent Technologies.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics